References
- 1. LYNCH DA, SIMONE PM, FOX MA, BURCHER BL, HEINIG MJ. CT features of pulmonary Mycobacterium avium complex infection. J Comput Assist Tomogr. 1995; 19(3): 353–60.
- 2. MOORE EH. Atypical mycobacterial infection in the lung: CT appearance. Radiology. 1993; 187(3): 777–82.
- 3. TANAKA E, AMITANI R, NIIMI A, SUZUKI K, MURAYAMA T, KUZE F. Yield of CT and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med. 1997; 155(6): 2041–6.
- 4. OBAYASHI Y, FUJITA J, SUEMITSU I, KAMEI T, NII M, TAKAHARA J. Successive follow-up of chest computed tomography in patients with Mycobacterium avium-intracellulare complex. Respir Med. 1999; 93(1): 11–15.
- 5. HONG SJ, KIM TJ, LEE JH, PARK JS. Nontuberculous mycobacterial pulmonary disease mimicking lung cancer: Clinicoradiologic features and diagnostic implications. Medicine (Baltimore). 2016; 95(26): e3978.
- 6. NAVID S, ARZHANG S, MIRZAEI A, KEFAYAT A, NADERI Z. Misleading of the diagnosis of Mycobacterium attributed lung diseases to malignancy due to smear, culture and PCR negative results: A lesson from a case report. Indian J Tuberc. 2020; 67(3): 371–3.
- 7. FOGLA S, PANSARE VM, CAMERO LG, SYEDA U, PATIL N, CHAUDHURY A. Cavitary lung lesion suspicious for malignancy reveals Mycobacterium xenopi. Respir Med Case Rep. 2018 Jan 3; 23: 83–5.
- 8. MEIER E, PENNINGTON K, GALLO DE MORAES A, ESCALANTE P. Characteristics of Mycobacterium avium complex (MAC) pulmonary disease in previously treated lung cancer patients. Respir Med Case Rep. 2017 Jun 23; 22: 70–3.
- 9. TEH RW, FEENEY K, FRANCIS RJ, PHILLIPS M, MILLWARD MJ. Mycobacterium mimicking metastatic melanoma. Intern Med J. 2013; 43(12): 1342–6.
- 10. BAE K, JUNG H, JEON KN, HYUN SD, KIM SH, KIM HC. Coexistence of nontuberculous mycobacterium and IgG4-related disease in a solitary pulmonary nodule: A case report. Medicine (Baltimore). 2019; 98(48): e18179.
- 11. GARG N, PUNCH C, STEIN M, SCHOFIELD C. When occam’s razor can fail- active mycobacteria infection and lung cancer: A case of neuroendocrine lung cancer diagnosed in the setting of refractory mycobacterium avium-intracellulare. Clin Case Rep. 2018; 6(11): 2156–9.
- 12. MATSUMOTO A, ENOMOTO T, MUROYA Y, SUGISAKI M, SHINGU A, SAITOH H, et al. Pulmonary non-tuberculous mycobacteriosis (Mycobacterium intracellulare) with cavities developing in a non-small cell lung cancer patient during chemotherapy. Nihon Kokyuki Gakkai Zasshi. 2010; 48(8): 609–13.
- 13. NAKAMURA Y, OKADA Y, ENDO C, AIKAWA H, SAKURADA A, SATO M, et al. Endobronchial carcinoid tumor combined with pulmonary non-tuberculous mycobacterial infection: report of two cases. Lung Cancer. 2003; 39(2): 227–9.
- 14. KAWATE E, YAMAZAKI M, KOHNO T, FUJIMORI S, TAKAHASHI H. Two cases with solitary pulmonary nodule due to non-tuberculous mycobacterial infection showing intense 18F-fluorodeoxyglucose uptake on positron emission tomography scan. Geriatr Gerontol Int. 2010; 10(3): 251–4.
- 15. MIN Z, AMLANI M. Pulmonary Mycobacterium kansasii Infection Mimicking Malignancy on the (18) F-FDG PET Scan in a Patient Receiving Etanercept: A Case Report and Literature Review. Case Rep Pulmonol. 2014; 2014: 973573.
- 16. LINDELL RM, HARTMAN TE, SWENSEN SJ, JETT JR, MIDTHUN DE, TAZELAAR HD, et al. Five-year lung cancer screening experience: CT appearance, growthrate, location, and histologic features of 61 lung cancers. Radiology. 2007; 242(2): 555–62.
- 17. HONDA O, JOHKOH T, SEKIGUCHI J, TOMIYAMA N, MIHARA N, SUMIKAWA H, et al. Doubling time of lung cancer determined using three-dimensional volumetric software: comparison of squamous cell carcinoma and adenocarcinoma. Lung Cancer. 2009; 66(2): 211–7.
- 18. ODA S, AWAI K, MURAO K, OZAWA A, UTSUNOMIYA D, YANAGA Y, et al. Volume-doubling time of pulmonary nodules with ground glass opacity at multidetector CT: assessment with computer-aided three-dimensional volumetry. Acad Radiol. 2011; 18(1): 63–9.
- 19. SCHWARTZ M. A biomathematical approach to clinical tumor growth. Cancer. 1961; 14: 1272–94.
- 20. BUDAK E, ÇOK G, AKGUN A. The Contribution of Fluorine (18)F-FDG PET/CT to Lung Cancer Diagnosis, Staging and Treatment Planning. Mol Imaging Radionucl Ther. 2018; 27(2): 73–80.
- 21. AL-SARRAF N, GATELY K, LUCEY J, AZIZ R, DODDAKULA K, WILSON L, et al. Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases. Eur J Cardiothorac Surg. 2008; 34(4): 892–7.
- 22. USUDA K, SAGAWA M, MOTONO N, UEDA M, TANAKA M, MACHIDA Y, et al. Diagnostic performance of diffusion weighted imaging of malignant and benign pulmonary nodules and masses: comparison with positron emission tomography. Asian Pac J Cancer Prev. 2014; 15(11): 4629–35.
- 23. CHRYSIKOS S, GKIOZOS I, DIMAKOU K, ZERVAS E, KAARAMPITSAKOS T, ANYFANTI M, et al. Clinical utility of thoracic endosonography (EBUS/EUS-b) in mediastinal staging of patients with non-small cell lung cancer: comparison with integrated PET/CT-a real-life prospective study in Greece. J Thorac Dis. 2020; 12(10): 5657–66.
- 24. ZHOU LM, YUAN LL, GAO Y, LIU XS, DAI Q, YANG JW, et al. Nucleophosmin 1 overexpression correlates with (18)F-FDG PET/CT metabolic parameters and improves diagnostic accuracy in patients with lung adenocarcinoma. Eur J Nucl Med Mol Imaging. 2020 Aug 27. doi: 10.1007/s00259-020-05005-4.